article thumbnail

Medicare Unveils First 10 Negotiated Drug Prices

Med Page Today

(MedPage Today) -- Sitagliptin (Januvia) saw the greatest drop in price among the list of 10 drugs whose new prices were announced Thursday under Medicare's drug price negotiation program. The price negotiation program was passed in 2022 as part.

Medicare 142
article thumbnail

Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients

Med Page Today

(MedPage Today) -- Medicare will cover the weight-loss drug semaglutide (Wegovy) under its Part D drug program for patients with overweight or obesity who have preexisting heart disease and need the drug to prevent heart attacks or strokes, the.

Medicare 132
article thumbnail

One Way to Spot Early Cognitive Decline? Medicare Wellness Visits

Med Page Today

(MedPage Today) -- A Medicare annual wellness visit (AWV) was associated with greater recognition of mild cognitive impairment in older adults, a population-based cohort study in Texas showed. Compared with those who didn't have an annual visit.

Medicare 122
article thumbnail

Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask.

Med Page Today

(MedPage Today) -- Physician and consumer groups expressed positive responses to Medicare's release Thursday of its price list for the first 10 negotiated drugs under its Drug Price Negotiation program, but the pharmaceutical industry was not so.

Medicare 122
article thumbnail

The heart of the question: Who can get Medicare-covered weight loss medicine?

Science Daily - Heart Disease

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.

Medicare 117
article thumbnail

ACC Disappointed by Lack of Medicare Fix in Recent Continuing Resolution

DAIC

By not including a fix to the 3.37% cut to the Medicare Physician Fee Schedule in the most recent continuing resolution, practices around the country are left in a state of uncertainty for their own futures, as well as patient access to care,” said American College of Cardiology President B.

Medicare 105
article thumbnail

HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage

DAIC

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104